ATHENS, GA / ACCESS Newswire / November 24, 2025 / NDT Pharmaceuticals Inc. (OTC:NDTP), a company focused on advancing sustainable health and wellness solutions, today announced a significant contract win for its wholly-owned subsidiary, Good Saltâ"¢ Life, LLC. The Tennessee Department of Correction (TDOC) has purchased Good Salt Life's ByoCart Sprayer units, Clean Republic Disinfectant to modernize hygiene and infection-control protocols across its correctional facilities, representing another major instit ...

Accessibility StatementSkip Navigation NEW YORK, Nov. 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Perrigo Company plc (NYSE: PRGO). CLASS PERIOD: February 27, 2023 to November 4, 2025 Shareholders who purchased shares of PRGO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/sec ...

NEW YORK, Nov. 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR). Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/atyr-pharma-inc-loss-submission-form/?id=178569&from=4 CLASS PERIOD: November 7, 202 ...

Shareholders who purchased shares of TLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. Accessibility StatementSkip Navigation NEW YORK, Nov. 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). CONTACT US HERE: https://securitiesclasslaw.com/securities/telix-pharmaceuticals-ltd-loss-submiss ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug ClassesMELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced positive preclinical results showing its proprietary gel formulation achieved substantially higher bioavailability than a leading on-market reference antihistamine product. In a comparative pharmacokinetic stu ...

New Taipei City, Taiwan, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced that the Company has entered into a non‑binding letter of intent (the “LOI”) wit ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Foundation today announced that it has committed over $3 million in grants to expand access to food in communities across the United States. Gilead Foundation Healing Hunger awards will enable 14 regionally focused organizations to meet the unique needs of their communities by improving long-term nutrition access. The funding, distributed through the Gilead Foundation, supports organizations addressing food insecurity in California, North Carolina, N. ...

BEDFORD, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced the presentation of new florbetaben F18 data at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) 2025 conference, taking place December 1-4, in San Diego, CA. Presentation details are as follows: Poster Presentation Date & Time: Wednesda ...

Group 1: Meta Platforms Inc. - Meta is accused of halting internal research that suggested users who stopped using Facebook experienced reduced depression and anxiety [2][3] - The study, initiated in 2019, aimed to investigate the effects of Meta's products on various social and psychological factors [3] - A Meta spokesperson refuted the allegations, claiming they are based on selective quotes and misleading interpretations [4] Group 2: Novo Nordisk A/S - Shares of Novo Nordisk fell over 10% following the announcement that its Alzheimer's trial did not meet its primary objective [4] - Analysts had anticipated the trial's challenges, although previous studies indicated potential benefits of semaglutide for Alzheimer's-related biomarkers [5] - Novo Nordisk's chief scientific officer emphasized the company's commitment to exploring semaglutide's potential despite low success probabilities [5] Group 3: Airlines Industry - U.S. airlines are preparing for a record Thanksgiving travel period, with an estimated 31 million passengers expected between November 21 and December 1 [6][7] - This surge in travel follows a federal government shutdown that disrupted travel for approximately 6 million flyers [7] - Air traffic controllers and technicians with perfect attendance during the shutdown will receive $10,000 bonuses [7] Group 4: Entertainment Industry - Universal's "Wicked: For Good" achieved around $150 million in domestic ticket sales during its opening weekend, marking the second-largest opening for a 2025 film [9] - The film's debut surpassed the first installment of "Wicked," released the previous year, and sold approximately 10 million tickets [10] - Industry experts suggest that this success could challenge the record set during the Thanksgiving film slate of 2024 [10]